Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating promising results in the treatment of type 2 diabetes. This artificial peptide duplicates the actions of naturally occurring GLP-1, a https://bookmarknap.com/story11330547/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes